Variants in Genes Involved in Functional Pathways Associated with Hypertension in African Americans

Clinical and Translational Science

Volumn 3, Issue 6, 2010, Pages 279-286

  Martinez Cantarin, Maria P ^a   Ertel, Adam ^b   Deloach, Stephanie ^a   Fortina, Paolo ^b   Scott, Kathryn ^b   Burns, Trudy L ^c   Falkner, Bonita ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

ACE; African Americans; Genetic variants; GRK4; Hypertension; NOS3

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; G PROTEIN COUPLED RECEPTOR KINASE 4;

ADULT; AFRICAN AMERICAN; ALLELISM; ARTICLE; BODY MASS; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GENE LOCUS; GENETIC MARKER; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AFRICAN AMERICANS; BLOOD PRESSURE; BODY SIZE; FEMALE; G-PROTEIN-COUPLED RECEPTOR KINASE 4; GENE FREQUENCY; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; INDEL MUTATION; INTRONS; LOGISTIC MODELS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; ODDS RATIO; PEPTIDYL-DIPEPTIDASE A; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 78650252496     PISSN: 17528054     EISSN: 17528062     Source Type: Journal    
DOI: 10.1111/j.1752-8062.2010.00242.x     Document Type: Article

References (46)

1. Lackland DT, Keil JE. Epidemiology of hypertension in African Americans. Semin Nephrol. 1996; 16: 63-70.
2. Keil JE, Sutherland SE, Knapp RG, Lackland DT, Gazes PC, Tyroler HA. Mortality rates and risk factors for coronary disease in black as compared with white men and women. N Engl J Med. 1993; 329: 73-78.
3. Cooper RS, Liao Y, Rotimi C. Is hypertension more severe among U.S. blacks, or is severe hypertension more common Ann Epidemiol. 1996; 6: 173-180.
4. Felder RA, Sanada H, Xu J, Yu PY, Wang Z, Watanabe H, Asico LD, Wang W, Zheng S, Yamaguchi I, Williams SM, Gainer J, Brown NJ, Hazen-Martin D, Wong LJ, Robillard JE, Carey RM, Eisner GM, Jose PA. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci U S A. 2002; 99: 3872-3877.
5. Hopkins PN, Hunt SC. Genetics of hypertension. Genet Med. 2003; 5: 413-429.
6. Munroe PB, Caulfield MJ. Genetics of hypertension. Curr Opin Genet Dev. 2000; 10: 325-329.
7. Turner ST, Boerwinkle E. Genetics of hypertension, target-organ complications, and response to therapy. Circulation. 2000; 102: IV40- IV45.
8. Weinberger MH. Salt sensitivity of blood pressure in humans. Hypertension. 1996; 27: 481-490.
9. Falkner B, Kushner H. Interaction of sodium sensitivity and stress in young adults. Hypertension. 1991; 17: I162- I165.
10. Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, Sherman PA, Sessa WC, Smithies O. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci U S A. 1996; 93: 13176-13181.
11. Sigmon DH, Beierwaltes WH. Angiotensin II: nitric oxide interaction and the distribution of blood flow. Am J Physiol. 1993; 265: R1276-R1283.
12. Malinski T. Understanding nitric oxide physiology in the heart: a nanomedical approach. Am J Cardiol. 2005; 96: 13i-24i.
13. Kalinowski L, Dobrucki IT, Malinski T. Race-specific differences in endothelial function: predisposition of African Americans to vascular diseases. Circulation. 2004; 109: 2511-2517.
14. Pereira TV, Rudnicki M, Cheung BM, Baum L, Yamada Y, Oliveira PS, Pereira AC, Krieger JE. Three endothelial nitric oxide (NOS3) gene polymorphisms in hypertensive and normotensive individuals: meta-analysis of 53 studies reveals evidence of publication bias. J Hypertens. 2007; 25: 1763-1774.
15. Overlack A, Ruppert M, Kolloch R, Gobel B, Kraft K, Diehl J, Schmitt W, Stumpe KO. Divergent hemodynamic and hormonal responses to varying salt intake in normotensive subjects. Hypertension. 1993; 22: 331-338.
16. Sullivan JM. Salt sensitivity. Definition, conception, methodology, and long-term issues. -Hypertension. 1991; 17: I61- I68.
17. Wallin JD. Hypertension in black patients. Epidemiologic and pathophysiologic considerations. J Clin Hypertens. 1986; 2: 7-12.
18. Rana BK, Insel PA, Payne SH, Abel K, Beutler E, Ziegler MG, Schork NJ, O'Connor DT. -Population-based sample reveals gene-gender interactions in blood pressure in White Americans. Hypertension. 2007; 49: 96-106.
19. Kainulainen K, Perola M, Terwilliger J, Kaprio J, Koskenvuo M, Syvanen AC, Vartiainen E, Peltonen L, Kontula K. Evidence for involvement of the type 1 angiotensin II receptor locus in essential hypertension. Hypertension. 1999; 33: 844-849.
20. Jiang X, Sheng H, Li J, Xun P, Cheng Y, Huang J, Xiao H, Zhan Y. Association between renin-angiotensin system gene polymorphism and essential hypertension: a community-based study. J Hum Hypertens. 2009; 23: 176-181.
21. Williams SM, Ritchie MD, Phillips JA 3rd, Dawson E, Prince M, Dzhura E, Willis A, Semenya A, Summar M, White BC, Addy JH, Kpodonu J, Wong LJ, Felder RA, Jose PA, Moore JH. Multilocus analysis of hypertension: a hierarchical approach. Hum Hered. 2004; 57: 28-38.
22. Howard TD, Giles WH, Xu J, Wozniak MA, Malarcher AM, Lange LA, Macko RF, Basehore MJ, Meyers DA, Cole JW, Kittner SJ. Promoter polymorphisms in the nitric oxide synthase 3 gene are associated with ischemic stroke susceptibility in young black women. Stroke. 2005; 36: 1848-1851.
23. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005; 111: 697-716.
24. Lohmueller KE, Wong LJ, Mauney MM, Jiang L, Felder RA, Jose PA, Williams SM. Patterns of genetic variation in the hypertension candidate gene GRK4: ethnic variation and haplotype structure. Ann Hum Genet. 2006; 70: 27-41.
25. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res. 1992; 20: 1433.
26. Shanmugam V, Sell KW, Saha BK. Mistyping ACE heterozygotes. PCR Methods Appl. 1993; 3: 120-121.
27. Zhu H, Lu Y, Wang X, Treiber FA, Harshfield GA, Snieder H, Dong Y. The G protein-coupled receptor kinase 4 gene affects blood pressure in young normotensive twins. Am J Hypertens. 2006; 19: 61-66.
28. Bhatnagar V, O'Connor DT, Brophy VH, Schork NJ, Richard E, Salem RM, Nievergelt CM, Bakris GL, Middleton JP, Norris KC, Wright J, Hiremath L, Contreras G, Appel LJ, Lipkowitz MS; AASK Study Investigators. G-protein-coupled receptor kinase 4 polymorphisms and blood pressure response to metoprolol among African Americans: sex-specificity and interactions. Am J Hypertens. 2009; 22(3): 332-338.
29. Wang Y, Li B, Zhao W, Liu P, Zhao Q, Chen S, Li H, Gu D. Association study of G protein-coupled receptor kinase 4 gene variants with essential hypertension in northern Han Chinese. Ann Hum Genet. 2006; 70: 778-783.
30. Gu D, Su S, Ge D, Chen S, Huang J, Li B, Chen R, Qiang B. Association study with 33 single-nucleotide polymorphisms in 11 candidate genes for hypertension in Chinese. Hypertension. 2006; 47: 1147-1154.
31. Speirs HJ, Katyk K, Kumar NN, Benjafield AV, Wang WY, Morris BJ. Association of G-protein-coupled receptor kinase 4 haplotypes, but not HSD3B1 or PTP1B polymorphisms, with essential hypertension. J Hypertens. 2004; 22: 931-936.
32. Bengra C, Mifflin TE, Khripin Y, Manunta P, Williams SM, Jose PA, Felder RA. Genotyping of essential hypertension single-nucleotide polymorphisms by a homogeneous PCR method with universal energy transfer primers. Clin Chem. 2002; 48: 2131-2140.
33. Zeng C, Villar VA, Eisner GM, Williams SM, Felder RA, Jose PA. G protein-coupled receptor kinase 4: role in blood pressure regulation. Hypertension. 2008; 51: 1449-1455.
34. Sanada H, Yatabe J, Midorikawa S, Hashimoto S, Watanabe T, Moore JH, Ritchie MD, Williams SM, Pezzullo JC, Sasaki M, Eisner GM, Jose PA, Felder RA. Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension. Clin Chem. 2006; 52: 352-360.
35. Duru K, Farrow S, Wang JM, Lockette W, Kurtz T. Frequency of a deletion polymorphism in the gene for angiotensin converting enzyme is increased in African-Americans with hypertension. Am J Hypertens. 1994; 7: 759-762.
36. Niu W, Qi Y, Hou S, Zhai X, Zhou W, Qiu C. Haplotype-based association of the renin-angiotensin-aldosterone system genes polymorphisms with essential hypertension among Han Chinese: the Fangshan study. J Hypertens. 2009; 27: 1384-1391.
37. Das M, Pal S, Ghosh A. Angiotensin converting enzyme gene polymorphism (insertion/deletion) and hypertension in adult Asian Indians: a population-based study from Calcutta, India. Hum Biol. 2008; 80: 303-312.
38. Caprioli J, Mele C, Mossali C, Gallizioli L, Giacchetti G, Noris M, Remuzzi G, Benigni A. Polymorphisms of EDNRB, ATG, and ACE genes in salt-sensitive hypertension. Can J Physiol Pharmacol. 2008; 86: 505-510.
39. Bautista LE, Vargas CI, Orostegui M, Gamarra G. Population-based case-control study of -renin-angiotensin system genes polymorphisms and hypertension among Hispanics. Hypertens Res. 2008; 31: 401-408.
40. Vimaleswaran KS, Franks PW, Barroso I, Brage S, Ekelund U, Wareham NJ, Loos RJ. Habitual energy expenditure modifies the association between NOS3 gene polymorphisms and blood pressure. Am J Hypertens. 2008; 21: 297-302.
41. Nejatizadeh A, Kumar R, Stobdan T, Goyal AK, Sikdar S, Gupta M, Javed S, Pasha MA. Endothelial nitric oxide synthase gene haplotypes and circulating nitric oxide levels significantly associate with risk of essential hypertension. Free Radic Biol Med. 2008; 44: 1912-1918.
42. Shoji M, Tsutaya S, Saito R, Takamatu H, Yasujima M. Positive association of endothelial nitric oxide synthase gene polymorphism with hypertension in northern Japan. Life Sci. 2000; 66: 2557-2562.
43. Miyamoto Y, Saito Y, Kajiyama N, Yoshimura M, Shimasaki Y, Nakayama M, Kamitani S, Harada M, Ishikawa M, Kuwahara K, Ogawa E, Hamanaka I, Takahashi N, Kaneshige T, Teraoka H, Akamizu T, Azuma N, Yoshimasa Y, Yoshimasa T, Itoh H, Masuda I, Yasue H, Nakao K. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension. 1998; 32: 3-8.
44. Niu WQ, Qi Y, Zhang LT, Qi YX, Wang B, Hou SQ, Zhai XY, Qiu CC. Endothelial nitric oxide synthase genetic variation and essential hypertension risk in Han Chinese: the Fangshan study. J Hum Hypertens. 2009; 23: 136-139.
45. Bhandary UV, Tse W, Yang B, Knowles MR, Demaine AG. Endothelial nitric oxide synthase -polymorphisms are associated with hypertension and cardiovascular disease in renal transplantation. Nephrology (Carlton). 2008; 13: 348-355.
46. Tsujita Y, Baba S, Yamauchi R, Mannami T, Kinoshita M, Yamamoto R, Katsuya T, Higaki J, Ogihara T, Ogata J, Iwai N. Association analyses between genetic polymorphisms of endothelial nitric oxide synthase gene and hypertension in Japanese: the Suita Study. J Hypertens. 2001; 19: 1941-1948.